Application no. and date | 19731334.9 (espacenet) (Federated) (European Patent Register), 20190503 | Patent/reg. no. and date | DK/EP 3793609, 20231213 | Publication date | 20210324 | Priority no. and date | US 201862671208 P, 20180514, US 201962835278 P, 20190417 | EP pub. no. and date |
EP 3793609 20210324 | Effective date | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | Applicant ref. no. | | Inventor | JAIN, Ashwinkumar, c/o Pfizer Inc. 445 Eastern Point Road, Building 98
Groton, Connecticut 06340, US, YU, Weili, c/o Pfizer Inc. 445 Eastern Point Road, Building 98
Groton, Connecticut 06340, US | Representative | | Opponent | | IPC Class | A61K 31/519 (2006.01) , A61K 47/12 (2006.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 9/00 (2006.01) | Title | ORAL SOLUTION FORMULATION | Int. application no. | IB2019053650 | Int. publication no. | WO2019220253 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|